Similar articles

• HDL-cholesterol in antihypertensive treatment. The Oslo Study.

  Helgeland A, Leren P, Enger SC, Hjermann I, Holme I. Helgeland A, et al. Acta Med Scand Suppl. 1979;625:131-4. doi: 10.1111/j.0954-6820.1979.tb00757.x. Acta Med Scand Suppl. 1979. PMID: 219665 Clinical Trial. No abstract available.
• Antihypertensive drugs and blood lipids: the Oslo study.

  Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG. Leren P, et al. J Cardiovasc Pharmacol. 1982;4 Suppl 2:S222-4. J Cardiovasc Pharmacol. 1982. PMID: 6177960
• High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study.

  Enger SC, Hjermann I, Foss OP, Helgeland A, Holme I, Leren P, Norum KR. Enger SC, et al. Artery. 1979 Feb;5(2):170-81. Artery. 1979. PMID: 231954
• Alcohol consumption and high-density lipoprotein cholesterol in marathon runners.

  [No authors listed] [No authors listed] Nutr Rev. 1981 Aug;39(8):303-4. doi: 10.1111/j.1753-4887.1981.tb06796.x. Nutr Rev. 1981. PMID: 7024857 Review. No abstract available.
• Reduction of low density and high density lipoprotein cholesterol by fat-modified diets. A survey of recent findings.

  Vessby B, Lithell H, Boberg J. Vessby B, et al. Hum Nutr Clin Nutr. 1982;36(3):203-11. Hum Nutr Clin Nutr. 1982. PMID: 6749766 Review.